Table 3.
Management and outcomes of the 30 patients with ACS and complete microbiological investigations.
| Outcomes | Bacterial ACS, n = 11 |
Non-bacterial ACS, n = 19 |
P valuea |
|---|---|---|---|
| ICU management, n (%) | |||
| Blood transfusion | 5 (45) | 6 (32) | 0.71 |
| Anticoagulation | 3 (27) | 9 (47) | 0.44 |
| High flow oxygen therapy | 2 (18) | 5 (26) | 1.00 |
| Invasive mechanical ventilation | 0 | 0 | – |
| Renal replacement therapy | 0 | 0 | – |
| Vasopressor support | 0 | 0 | – |
| Bilateral lung injury, n (%) | 2 (18) | 2 (11) | 0.61 |
| Antimicrobial therapy | |||
| Overall duration (days), median [25–75] | 7 [7–10] | 8 [7–10] | 0.38 |
| Secondarily narrowed, n (%) | 11 (100) | 12 (63) | 0.014 |
| Length of stay (days), median [25–75] | |||
| ICU | 3 [2–7] | 4 [3–5] | 0.37 |
| Hospital | 11 [6–12] | 8 [7–10] | 0.63 |
ICU: intensive care unit.
aResults are reported as number (percentage) or median [inter-quartile range]. The corresponding between-groups comparisons were performed using the Fisher’s exact test and the Mann–Whitney test, respectively.